1. Initiate buy on Essel Propack on improving RoE: Edelweiss

Initiate buy on Essel Propack on improving RoE: Edelweiss

Initiate coverage on Essel Propack (EPL) with a ‘buy’ rating and target price of R184 per share...

By: | Published: March 17, 2015 12:13 AM

Initiate coverage on Essel Propack (EPL) with a ‘buy’ rating and target price of R184 per share valuing at 7x FY17e EV/ebitda, implying a discount of 21% on EV/ebitda and 27% on P/E compared to global peers. Adhering to the growth cornerstones of innovation and customer-driven R&D, the company has captured one-third market share in laminated tubes.

We expect RoE to exceed 21% in FY17 from 13.5% in FY14 as: (1) penetration in non-oral care segment is on the rise; and (2) subsidiaries in Europe and America are turning profitable. While EPL has historically traded at 5-7x EV/ebitda band, we have valued it at 7x considering that EPL’s RoE will transcend its historical range of 8-10%. Our target EV/ebitda is at 21% discount to global peers despite EPL’s margins being much higher.

We expect increase in asset turn and higher PAT margins to catapult EPL’s RoE to 21.3% in FY17e. Consequently, PAT will post CAGR of 27.0% over FY14-17e.

EPL has enhanced its laminated tubes market share from 28% in CY02 to 34% currently. To propel growth, EPL has set sights on the global 22bn tubes non-oral market. We expect non-oral revenue CAGR of 15% over FY14-17e, riding conversions in US & Europe and growth in cosmetics, foods & pharma in China & India.

Calculate your income tax post budget 2018 through this Income Tax Calculator, get latest news on Budget 2018 and Auto Expo 2018. Like us on Facebook and follow us on Twitter.

  1. No Comments.

Go to Top